AI
APTO

Atom Investors’s Aptose Biosciences, Inc. APTO Stock Holding History

Atom Investors’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-80
Closed -$158K – 455
2020
Q4 		$158K Sell
80
-847
-91% -$1.99M 0.02% 328
2020
Q3 		$2.5M Buy
927
+343
+59% +$855K 0.24% 100
2020
Q2 		$1.66M Buy
584
+60
+11% +$194K 0.11% 160
2020
Q1 		$1.4M Buy
+524
New +$1.56M 0.12% 136

Other funds holding APTO

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Atom Investors's APTO Position: Q1 2021 in Review

Atom Investors sold out of Aptose Biosciences, Inc. (APTO) in Q1 2021, closing a stake of 80 shares — an estimated $158K sold.

Atom Investors first reported a position in APTO in Q1 2020 and held it in 4 quarters. The position peaked at $2.5M in Q3 2020. 70 funds tracked by Wall St. Rank hold APTO as of Q1 2021.

  • Atom Investors reported no remaining Aptose Biosciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Atom Investors sold 80 Aptose Biosciences, Inc. shares in Q1 2021, an estimated $158K.
  • Atom Investors first reported a position in Aptose Biosciences, Inc. in Q1 2020 and held it in 4 quarters.
  • Atom Investors's Aptose Biosciences, Inc. position peaked at $2.5M in Q3 2020.
  • 70 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2021.

Based on Atom Investors's 13F filing for Q1 2021, filed 17 May 2021.